These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32235863)

  • 41. INSL5 activates multiple signalling pathways and regulates GLP-1 secretion in NCI-H716 cells.
    Ang SY; Evans BA; Poole DP; Bron R; DiCello JJ; Bathgate RAD; Kocan M; Hutchinson DS; Summers RJ
    J Mol Endocrinol; 2018 Apr; 60(3):213-224. PubMed ID: 29535183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.
    Shabanpoor F; Akhter Hossain M; Ryan PJ; Belgi A; Layfield S; Kocan M; Zhang S; Samuel CS; Gundlach AL; Bathgate RA; Separovic F; Wade JD
    J Med Chem; 2012 Feb; 55(4):1671-81. PubMed ID: 22257012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. INSL5 may be a unique marker of colorectal endocrine cells and neuroendocrine tumors.
    Mashima H; Ohno H; Yamada Y; Sakai T; Ohnishi H
    Biochem Biophys Res Commun; 2013 Mar; 432(4):586-92. PubMed ID: 23438439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
    Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
    Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. INSL5 is a high affinity specific agonist for GPCR142 (GPR100).
    Liu C; Kuei C; Sutton S; Chen J; Bonaventure P; Wu J; Nepomuceno D; Kamme F; Tran DT; Zhu J; Wilkinson T; Bathgate R; Eriste E; Sillard R; Lovenberg TW
    J Biol Chem; 2005 Jan; 280(1):292-300. PubMed ID: 15525639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7.
    Liu C; Chen J; Kuei C; Sutton S; Nepomuceno D; Bonaventure P; Lovenberg TW
    Mol Pharmacol; 2005 Jan; 67(1):231-40. PubMed ID: 15465925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. INSL5 is a novel marker for human enteroendocrine cells of the large intestine and neuroendocrine tumours.
    Thanasupawat T; Hammje K; Adham I; Ghia JE; Del Bigio MR; Krcek J; Hoang-Vu C; Klonisch T; Hombach-Klonisch S
    Oncol Rep; 2013 Jan; 29(1):149-54. PubMed ID: 23128569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting the relaxin/insulin-like family peptide receptor 1 and 2 with small molecule compounds.
    Ng HH; Esteban-Lopez M; Agoulnik AI
    Mol Cell Endocrinol; 2019 May; 487():40-44. PubMed ID: 30590098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Indole-Containing Amidinohydrazones as Nonpeptide, Dual RXFP3/4 Agonists: Synthesis, Structure-Activity Relationship, and Molecular Modeling Studies.
    Guan D; Rahman MT; Gay EA; Vasukuttan V; Mathews KM; Decker AM; Williams AH; Zhan CG; Jin C
    J Med Chem; 2021 Dec; 64(24):17866-17886. PubMed ID: 34855388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a Testing Funnel for Identification of Small-Molecule Modulators Targeting Secretin Receptors.
    Dengler DG; Sun Q; Holleran J; Pollari S; Beutel J; Brown BT; Shinoki Iwaya A; Ardecky R; Harikumar KG; Miller LJ; Sergienko EA
    SLAS Discov; 2021 Jan; 26(1):1-16. PubMed ID: 32749201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural properties of relaxin chimeras.
    Haugaard-Jönsson LM; Hossain MA; Daly NL; Bathgate RA; Wade JD; Craik DJ; Rosengren KJ
    Ann N Y Acad Sci; 2009 Apr; 1160():27-30. PubMed ID: 19416154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis.
    McBride A; Hoy AM; Bamford MJ; Mossakowska DE; Ruediger MP; Griggs J; Desai S; Simpson K; Caballero-Hernandez I; Iredale JP; Pell T; Aucott RL; Holmes DS; Webster SP; Fallowfield JA
    Sci Rep; 2017 Sep; 7(1):10806. PubMed ID: 28883402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relaxin family peptides and their receptors.
    Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
    Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
    Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
    Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework.
    Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ
    Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Membrane receptors: structure and function of the relaxin family peptide receptors.
    Kong RC; Shilling PJ; Lobb DK; Gooley PR; Bathgate RA
    Mol Cell Endocrinol; 2010 May; 320(1-2):1-15. PubMed ID: 20138959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and Characterization of the R27S Genetic Variant of Insulin-like Peptide 5.
    Zaykov AN; Gelfanov VM; Liu F; DiMarchi RD
    ChemMedChem; 2018 Apr; 13(8):852-859. PubMed ID: 29466617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relaxin family peptide receptors and their ligands: new developments and paradigms in the evolution from jawless fish to mammals.
    Yegorov S; Bogerd J; Good SV
    Gen Comp Endocrinol; 2014 Dec; 209():93-105. PubMed ID: 25079565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Japanese medaka as a model for studying the relaxin family genes involved in neuroendocrine regulation: Insights from the expression of fish-specific rln3 and insl5 and rxfp3/4-type receptor paralogues.
    Alnafea H; Vahkal B; Zelmer CK; Yegorov S; Bogerd J; Good SV
    Mol Cell Endocrinol; 2019 May; 487():2-11. PubMed ID: 30703485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3).
    van der Westhuizen ET; Christopoulos A; Sexton PM; Wade JD; Summers RJ
    Mol Pharmacol; 2010 May; 77(5):759-72. PubMed ID: 20159943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.